Accès gratuit
Med Sci (Paris)
Volume 32, Numéro 3, Mars 2016
Page(s) 260 - 266
Section M/S Revues
Publié en ligne 23 mars 2016
  1. Maziak W, Behrens T, Brasky TM, et al. Are asthma and allergies in children and adolescents increasing? Results from ISAAC phase I and phase III surveys in Munster. Germany. Allergy 2003 ; 58 : 572–579. [CrossRef]
  2. Saito H. Much atopy about the skin: genome-wide molecular analysis of atopic eczema. Int Arch Allergy Immunol 2005 ; 137 : 319–325. [CrossRef] [PubMed]
  3. Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010 ; 105 : 99–106; quiz 7–9, 17. [CrossRef] [PubMed]
  4. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999 ; 17 : 255–281. [CrossRef] [PubMed]
  5. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004 ; 59 : 469–478. [CrossRef] [PubMed]
  6. Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997 ; 385 : 640–644. [CrossRef] [PubMed]
  7. Booth BW, Sandifer T, Martin EL, Martin LD. IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17. Respir Res 2007 ; 8 : 51. [CrossRef] [PubMed]
  8. Hartl D, He CH, Koller B, et al. Acidic mammalian chitinase is secreted via an ADAM17/epidermal growth factor receptor-dependent pathway and stimulates chemokine production by pulmonary epithelial cells. J Biol Chem 2008 ; 283 : 33472–33482. [CrossRef] [PubMed]
  9. Nakayama T, Watanabe Y, Oiso N, et al. Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1. J Immunol 2010 ; 185 : 6472–6479. [CrossRef]
  10. Schwaeble WJ, Stover CM, Schall TJ, et al. Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Lett 1998 ; 439 : 203–207. [CrossRef] [PubMed]
  11. Lucas AD, Chadwick N, Warren BF, et al. The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol 2001 ; 158 : 855–866. [CrossRef] [PubMed]
  12. Rimaniol AC, Till SJ, Garcia G, et al. The CX3C chemokine fractalkine in allergic asthma and rhinitis. J Allergy Clin Immunol 2003 ; 112 : 1139–1146. [CrossRef] [PubMed]
  13. Echigo T, Hasegawa M, Shimada Y, et al. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. J Allergy Clin Immunol 2004 ; 113 : 940–948. [CrossRef] [PubMed]
  14. El-Shazly A, Berger P, Girodet PO, et al. Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J Immunol 2006 ; 176 : 1860–1868. [CrossRef]
  15. Kim KW, Vallon-Eberhard A, Zigmond E, et al. In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. Blood 2011 ; 118 : e156–e167. [CrossRef] [PubMed]
  16. Harrison JK, Jiang Y, Chen S, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 1998 ; 95 : 10896–10901. [CrossRef]
  17. Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997 ; 91 : 521–530. [CrossRef] [PubMed]
  18. Jung S, Aliberti J, Graemmel P, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000 ; 20 : 4106–4114. [CrossRef] [PubMed]
  19. Chang SY, Song JH, Guleng B, et al. Circulatory antigen processing by mucosal dendritic cells controls CD8+ T cell activation. Immunity 2013 ; 38 : 153–165. [CrossRef] [PubMed]
  20. Liu ZQ, Wu Y, Song JP, et al. Tolerogenic CX3CR1+ B cells suppress food allergy-induced intestinal inflammation in mice. Allergy 2013 ; 68 : 1241–1248. [CrossRef] [PubMed]
  21. Fraticelli P, Sironi M, Bianchi G, et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 2001 ; 107 : 1173–1181. [CrossRef] [PubMed]
  22. Ning W, Li CJ, Kaminski N, et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 2004 ; 101 : 14895–14900. [CrossRef]
  23. Balabanian K, Foussat A, Dorfmuller P, et al. CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 2002 ; 165 : 1419–1425. [CrossRef] [PubMed]
  24. Marasini B, Cossutta R, Selmi C, et al. Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension. Clin Dev Immunol 2005 ; 12 : 275–279. [CrossRef] [PubMed]
  25. Murphy G, Caplice N, Molloy M. Fractalkine in rheumatoid arthritis: a review to date. Rheumatology (Oxford) 2008 ; 47 : 1446–1451. [CrossRef] [PubMed]
  26. Lesnik P, Haskell CA, Charo IF. Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 2003 ; 111 : 333–340. [CrossRef] [PubMed]
  27. Tremblay K, Lemire M, Provost V, et al. Association study between the CX3CR1 gene and asthma. Genes Immun 2006 ; 7 : 632–639. [CrossRef]
  28. Depner M, Kormann MS, Klopp N, et al. CX3CR1 Polymorphisms are associated with atopy but not asthma in German children. Int Arch Allergy Immunol 2007 ; 144 : 91–94. [CrossRef] [PubMed]
  29. Mionnet C, Buatois V, Kanda A, et al. CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung. Nat Med 2010 ; 16 : 1305–1312. [CrossRef] [PubMed]
  30. Staumont-Salle D, Fleury S, Lazzari A, et al. CX3CL1 (fractalkine) and its receptor CX3CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin. J Exp Med 2014 ; 211 : 1185–1196. [CrossRef] [PubMed]
  31. Nishimura M, Umehara H, Nakayama T, et al. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 2002 ; 168 : 6173–6180. [CrossRef]
  32. Garin A, Pellet P, Deterre P, et al. Cloning and functional characterization of the human fractalkine receptor promoter regions. Biochem J 2002 ; 368 : 753–760. [CrossRef] [PubMed]
  33. Ramos MV, Fernandez GC, Brando RJ, et al. Interleukin-10 and interferon-gamma modulate surface expression of fractalkine-receptor (CX(3)CR1) via PI3K in monocytes. Immunology 2010 ; 129 : 600–609. [CrossRef] [PubMed]
  34. Sechler JM, Barlic J, Grivel JC, Murphy PM. IL-15 alters expression and function of the chemokine receptor CX3CR1 in human NK cells. Cell Immunol 2004 ; 230 : 99–108. [CrossRef] [PubMed]
  35. Meucci O, Fatatis A, Simen AA, Miller RJ. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA 2000 ; 97 : 8075–8080. [CrossRef]
  36. Tong N, Perry SW, Zhang Q, et al. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol 2000 ; 164 : 1333–1339. [CrossRef]
  37. Boehme SA, Lio FM, Maciejewski-Lenoir D, et al. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol 2000 ; 165 : 397–403. [CrossRef]
  38. Mizuno T, Kawanokuchi J, Numata K, Suzumura A. Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res 2003 ; 979 : 65–70. [CrossRef] [PubMed]
  39. Landsman L, Bar-On L, Zernecke A, et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2009 ; 113 : 963–972. [CrossRef] [PubMed]
  40. Maciejewski-Lenoir D, Chen S, Feng L, et al. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J Immunol 1999 ; 163 : 1628–1635.
  41. Cambien B, Pomeranz M, Schmid-Antomarchi H, et al. Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood 2001 ; 97 : 2031–2037. [CrossRef] [PubMed]
  42. Meucci O, Fatatis A, Simen AA, et al. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 1998 ; 95 : 14500–14505. [CrossRef]
  43. Kansra V, Groves C, Gutierrez-Ramos JC, Polakiewicz RD. Phosphatidylinositol 3-kinase-dependent extracellular calcium influx is essential for CX(3)CR1-mediated activation of the mitogen-activated protein kinase cascade. J Biol Chem 2001 ; 276 : 31831–31838. [CrossRef] [PubMed]
  44. Davis CN, Harrison JK. Proline 326 in the C terminus of murine CX3CR1 prevents G-protein and phosphatidylinositol 3-kinase-dependent stimulation of Akt and extracellular signal-regulated kinase in Chinese hamster ovary cells. J Pharmacol Exp Ther 2006 ; 316 : 356–363. [CrossRef] [PubMed]
  45. Combadiere C, Gao J, Tiffany HL, Murphy PM. Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine. Biochem Biophys Res Commun 1998 ; 253 : 728–732. [CrossRef] [PubMed]
  46. Lopez Vina A. Severe asthma refractory to treatment: concepts and realities. Arch Bronconeumol 2006 ; 42 : 20–25. [CrossRef]
  47. O’Byrne PM. The demise of anti IL-5 for asthma, or not. Am J Respir Crit Care Med 2007 ; 176 : 1059–1060. [CrossRef] [PubMed]
  48. Froidure A, Charles P. Les cellules dendritiques humaines dans l’asthme et la rhinite allergique. Med Sci (Paris) 2015 ; 31 : 151–158. [CrossRef] [EDP Sciences] [PubMed]
  49. De Masson A, Bouaziz JD, Battistella M, et al. Immunopathologie du psoriasis : from bench to bedside. Med Sci (Paris) 2016 ; 32 : 253–259. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.